- Home
- H vs BAX Comparison
H vs BAX Comparison
Compare H & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- H
- BAX
- Stock Information
- Founded
- H 1957
- BAX 1931
- Country
- H United States
- BAX United States
- Employees
- H N/A
- BAX N/A
- Industry
- H Hotels/Resorts
- BAX Medical/Dental Instruments
- Sector
- H Consumer Discretionary
- BAX Health Care
- Exchange
- H Nasdaq
- BAX Nasdaq
- Market Cap
- H 15.5B
- BAX 15.1B
- IPO Year
- H 2009
- BAX N/A
- Fundamental
- Price
- H $161.04
- BAX $29.47
- Analyst Decision
- H Buy
- BAX Hold
- Analyst Count
- H 19
- BAX 10
- Target Price
- H $152.39
- BAX $40.90
- AVG Volume (30 Days)
- H 631.6K
- BAX 5.0M
- Earning Date
- H 02-13-2025
- BAX 02-06-2025
- Dividend Yield
- H 0.38%
- BAX 3.52%
- EPS Growth
- H 192.44
- BAX N/A
- EPS
- H 13.18
- BAX 0.21
- Revenue
- H $6,462,000,000.00
- BAX $15,062,000,000.00
- Revenue This Year
- H $2.40
- BAX N/A
- Revenue Next Year
- H $3.57
- BAX $6.58
- P/E Ratio
- H $12.13
- BAX $123.91
- Revenue Growth
- H 4.01
- BAX 32.37
- 52 Week Low
- H $124.40
- BAX $28.62
- 52 Week High
- H $168.20
- BAX $44.01
- Technical
- Relative Strength Index (RSI)
- H 46.18
- BAX 34.00
- Support Level
- H $151.06
- BAX $28.62
- Resistance Level
- H $163.55
- BAX $30.29
- Average True Range (ATR)
- H 4.23
- BAX 0.76
- MACD
- H -0.93
- BAX -0.15
- Stochastic Oscillator
- H 20.89
- BAX 26.43
About H Hyatt Hotels Corporation
Hyatt is an operator of owned (4% of total rooms) and managed and franchised (96%) properties across around 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 54% Americas, 22% rest of world, and 23% Asia-Pacific.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.